Neuphoria Therapeutics Statistics
NASDAQ: NEUPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.35+0.03 (+1.29%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Neuphoria Therapeutics by the numbers
Neuphoria Therapeutics has a market capitalization of $12.7 million based on 5.41M shares outstanding. With trailing EPS of $-2.07, Neuphoria Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 27.2% below its 50-day average and 42.1% below its 200-day average.
Average daily trading volume is 26.53K shares, or about $62,336 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NEUP valuation vs. peer median
| Metric | NEUP | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.72M | $13.01M | -2% |
| Avg. volume | 26.53K | 259.61K | -90% |
Peer median across 8 companies: ALLR, MCRB, MIRA, BOLT, TVRD, ACTU, BYSI, CTXR.
Valuation
- Market cap
- $12.72M
- Price / sales (latest FY)
- 10.83
- EPS (TTM)
- $-2.07
- Shares outstanding
- 5.41M
Price and trading
- Previous close
- 2.32
- Open
- 2.33
- Day range
- 2.27 – 2.38
- 52-week range
- 2.26 – 5.53
- 52-week change
- -47.31%
- Beta
- —
- Volume
- 55.96K
- Average volume
- 26.53K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Mar 13, 2025
Additional statistics
- Market Cap
- 12.72M
- Forward Pe
- -0.96
- Eps
- -2.07
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.53
- Week52 Low
- 2.26
- Avg Volume
- 26,526.00
- Shares Outstanding
- 5.41M
- Ma50
- 3.23
- Ma200
- 4.06
- Earnings Date
- Mar 13, 2025
- Pct From52w High
- -57.50%
- Pct From52w Low
- 3.98%